Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Monomorphic Epitheliotropic Intestinal T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas [Phase 1, Phase 2]
A study of DR-01 by Dren Bio is ongoing in Phase 1/Phase 2 to treat several T-cell and NK-cell lymphomas, with recruitment currently underwa…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in …